2026 NPPES data Urology Physician NPI 1417920349 MD
Verify on CMS →

MARK EHRENPREIS, MD

Urology Physician in FOREST HILLS, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
972
Medicare Part D claims · 179 beneficiaries · Urology Physician avg: 1K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MARK EHRENPREIS, MD filed 972 Medicare Part D claims in 2023 as a Urology Physician in FOREST HILLS, New York, prescribing 85% generic.

972
Part D claims, 2023
85%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK EHRENPREIS, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

972 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MARK EHRENPREIS, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK EHRENPREIS, MD?

Quality data not reported

NPI registry status

Active

Issued 02/10/2006

NPI 1417920349

Primary specialty

Urology Physician

Mid-sized

13,350 US NPIs in this specialty

Medicare Part D claims

972 24% vs specialty avg

2023 prescription claims

Specialty avg: 1,280

Specialty distribution in New York

How Urology Physician compares to other specialties among New York providers

New York providers

Urology Physician share within New York

1. Urology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Urology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Urology Physician ABMS/AOA estimate

Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Urology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK EHRENPREIS, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 11203 QUEENS BLVD STE 200, FOREST HILLS, NY, 11375, with a listed phone of (718) 805-8534. NPI 1417920349 was issued on 02/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what EHRENPREIS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 972 prescription claims written by this provider, covering 179 Medicare beneficiaries and totaling roughly $180K in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11203 QUEENS BLVD STE 200
FOREST HILLS, NY 11375

Provider Details

NPI 1417920349
Specialty Urology Physician
Credentials MD
Gender Male
NPI Issued 02/10/2006

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MARK EHRENPREIS, MD. To verify MARK EHRENPREIS, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK EHRENPREIS, MD — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 972 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

972
Total Claims
$180K
Total Drug Cost
179
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,212
Total Day Supply
33,856
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$149K
Generic Drug Cost
$31K
Antibiotic Claims
80

Patient Demographics

Average Patient Age
71.8 years
Avg HCC Risk Score
1.13
Gender Split
16% female / 84% male
Age Distribution
<65: 22, 65-74: 94, 75-84: 50, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK EHRENPREIS, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Tamsulosin Hcl
246
Finasteride
119
Oxybutynin Chloride Er
Oxybutynin Chloride
80
Alfuzosin Hcl Er
Alfuzosin Hcl
70
Bicalutamide
51
Desmopressin Acetate
37
Myrbetriq
Mirabegron
31
Ciprofloxacin Hcl
29
Tolterodine Tartrate Er
Tolterodine Tartrate
28
Lupron Depot
Leuprolide Acetate
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urology Physician Overview

How MARK EHRENPREIS, MD fits within the Urology Physician landscape nationally.

13,350
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider

MARK EHRENPREIS, MD's 972 claims are below the specialty average of 1,280.

Nearby Urology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as EHRENPREIS.

Compare Urology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK EHRENPREIS, MD's specialty?
MARK EHRENPREIS, MD specializes in Urology Physician and practices in FOREST HILLS, New York. Credentials: MD.
How much does MARK EHRENPREIS, MD prescribe under Medicare Part D?
In 2023, MARK EHRENPREIS, MD wrote 972 Medicare Part D claims totaling $180K in drug costs for 179 beneficiaries.
Where is MARK EHRENPREIS, MD located?
MARK EHRENPREIS, MD is located at 11203 QUEENS BLVD STE 200, FOREST HILLS, NY, 11375. Phone: (718) 805-8534.
What is MARK EHRENPREIS, MD's NPI number?
MARK EHRENPREIS, MD's National Provider Identifier (NPI) is 1417920349, issued on 02/10/2006.
Does MARK EHRENPREIS, MD prescribe more brand-name or generic drugs?
MARK EHRENPREIS, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $149K in brand drug costs.
How many Urology Physician providers are there in the US?
There are 13,350 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does MARK EHRENPREIS, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK EHRENPREIS, MD's most frequently prescribed drugs include Tamsulosin Hcl, Finasteride, Oxybutynin Chloride Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK EHRENPREIS, MD accept Medicare?
MARK EHRENPREIS, MD appears in CMS Medicare data with 972 Part D claims and 179 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK EHRENPREIS, MD's credentials?
MARK EHRENPREIS, MD's NPI is 1417920349 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology